Tissue repair processes

"Tissue repair processes" is not a specific molecule, receptor, or canonical therapeutic target. Instead, it refers broadly to the complex sequence of biological events that restore tissue integrity after injury. These processes include hemostasis (blood clotting), inflammation (immune cell recruitment and debris clearance), proliferation (cell growth and migration for new tissue formation), angiogenesis (new blood vessel formation), extracellular matrix deposition and remodeling, and maturation/remodeling phases where the repaired tissue regains strength and function[1][2][4][5]. Multiple cell types—such as fibroblasts, keratinocytes, endothelial cells—and signaling molecules—like growth factors (e.g., EGF family members, hepatocyte growth factor)—are involved in orchestrating these stages[1]. Because "tissue repair processes" describes a set of coordinated physiological responses rather than a discrete molecular entity or druggable target class like an enzyme or receptor, it is not considered a canonical therapeutic target. Summary of issues: The entry "Tissue repair processes" is too broad and does not refer to any single molecule or receptor; therefore it cannot be mapped to structured information about a specific drug target. It encompasses multiple pathways and mediators rather than one defined protein or gene product suitable for targeted therapy development[1][2][3].